Solid Biosciences Inc. (SLDB) Financials
SLDB Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 164.9 million | 38.5 million |
2023-09-30 | 184.7 million | 40.4 million |
2023-06-30 | 204.7 million | 41.0 million |
2023-03-31 | 229.6 million | 45.8 million |
SLDB Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -20.9 million | 1.9 million |
2023-09-30 | -18.3 million | 1.6 million |
2023-06-30 | -28.0 million | 1.9 million |
2023-03-31 | -28.5 million | 2.1 million |
SLDB Net Income
No data available :(
SLDB Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 123.6 million | - | 26.3 million |
2023-09-30 | 142.9 million | - | 26.8 million |
2023-06-30 | 160.2 million | - | 27.4 million |
2023-03-31 | 185.5 million | - | 27.8 million |
SLDB Shares Outstanding
SLDB Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 90000 | 15.5 million | 6.8 million | 587000 |
2023-09-30 | 383000 | 16.7 million | 6.4 million | - |
2023-06-30 | 536000 | 19.8 million | 7.1 million | - |
2023-03-31 | 506000 | 24.6 million | 7.4 million | - |
SLDB Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 587000 |
2023-09-30 | - | 588000 |
2023-06-30 | - | 703000 |
2023-03-31 | - | 1.1 million |
SLDB
Price: $10.10
52 week price:
Earnings Per Share: -4.83 USD
P/E Ratio: 0.10
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 27300
Market Capitalization: 378.9 million